Kannalife, Inc. – A Phyto-Medical CompanyNews Archives - Kannalife, Inc.

The Ghosts of the NFL (The Players’ Tribune)

December 24, 2015 |In the News , National Media , News

“CTE is the NFL’s industrial disease … Unless the NFL makes a serious shift, it’s very difficult to believe that it will continue to be the most popular sports league in America.” Former lineman Marvin Washington on why the future […]
‘Concussion’ doctor aiding marijuana-based research company

November 3, 2015 |In the News , National Media , News

The doctor portrayed in the upcoming football movie “Concussion” is on the board of a company looking for a marijuana-based treatment for head injuries. Bennet Omalu was recently named to the scientific advisory board of Kannalife Sciences, which has been […]
Kannalife Sciences, Inc. Signs Research and Development Agreements With Advanced Neural Dynamics and IteraMed in the Discovery of Novel Neuroprotectants

April 4, 2013 |Press Release

NEW YORK, April 4, 2013 — Kannalife Sciences, Inc. (“Kannalife”) announces its collaboration with two experienced drug discovery organizations: Advanced Neural Dynamics and IteraMed. Kannalife will fund a new drug discovery project related to a laboratory validated phytochemical. The founding […]
Kannalife Sciences Announces $1.5M Series A Financing From Medical Marijuana Inc. (OTC:MJNA) And CannaVest Corp. (OTC:FCLS)

March 7, 2013 |Press Release

NEW YORK, March 7, 2013 — Kannalife Sciences, Inc. (“Kannalife”) the phyto-medical company that specializes in the research & development of pharmacological products derived from botanical sources, announced today the entry into Series A financing totaling $1.5 million. The investment […]
Kannalife Sciences, Inc. Signs Exclusive License Agreement with National Institutes of Health Office of Technology Transfer (NIH-OTT)

July 9, 2012 |Press Release

NEW YORK, July 9, 2012 — Kannalife Sciences, Inc. (“Kannalife”) Signs Exclusive License Agreement With National Institutes of Health – Office of Technology Transfer (“NIH-OTT”) for the Commercialization of U.S. Patent 6,630,507, “Cannabinoids as Antioxidants and Neuroprotectants” (the “‘507 Patent”). […]
Prospective Grant of Exclusive License: Development of Cannabinoid(s) and Cannabidiol(s)

November 17, 2011 |Press Release

http://federalregister.gov/a/2011-29726 SUMMARY This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR part 404.7(a)(1)(i), that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to practice the […]

Archives

The Ghosts of the NFL (The Players’ Tribune)

‘Concussion’ doctor aiding marijuana-based research company

Kannalife Sciences, Inc. Signs Research and Development Agreements With Advanced Neural Dynamics and IteraMed in the Discovery of Novel Neuroprotectants

Kannalife Sciences Announces $1.5M Series A Financing From Medical Marijuana Inc. (OTC:MJNA) And CannaVest Corp. (OTC:FCLS)

Kannalife Sciences, Inc. Signs Exclusive License Agreement with National Institutes of Health Office of Technology Transfer (NIH-OTT)

Prospective Grant of Exclusive License: Development of Cannabinoid(s) and Cannabidiol(s)

Categories

Recent posts

Kannalife, Inc. to Present Breakthrough CIPN Study Findings on the Comparison of KLS-13019 to CBD at 29th Annual International Cannabinoid Research Society Conference

Kannalife Inc. Publishes New Research on Chemotherapy-Induced Peripheral Neuropathy

Kannalife Spokesman former NFL kicker Nick Lowery on Head Injuries, CBD Treatment

Kannalife Spokesman Nick Lowery Wins 2018 CNBC Stock Draft

Archives

Categories

Recent posts

Tags